Clinical Trial Update: Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 trial updating comparison of lefamulin to moxifloxacin for treatment of adults with community-acquired pneumonia completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Lefamulin (Lefamulin)
• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Nabriva Therapeutics AG | Conditions: Community Acquired Pneumonia | Phase 3 | Status: COMPLETED | Results posted: 2019-10-23